$KEYS

CULLEN JAMES sold $1.0M of KEYS

CULLEN JAMES sold 3,000 shares of Keysight Technologies, Inc. (KEYS) at $346.58 ($1.04M total) on 2026-06-02.

Original reporting
SEC EDGAR · CULLEN JAMES
Published Jun 4, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 4, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$KEYS
Neutral
medium confidence
Mentioned
$KEYS
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KEYSNeutralLow
01

Why it matters

This disclosure may influence short-term sentiment/positioning, but the article provides no fundamental catalyst (earnings, guidance, deal, litigation, or regulatory action).

02

Market read

Traders may monitor for follow-on insider activity or correlate with near-term price/volume, but the standalone signal is weak.

03

What to watch

No 10b5-1 plan is cited, but the article does not provide context on prior holdings, total planned sales, or whether this is part of a broader pattern.

Relevance 6/10Novelty 3/10Timing: SEC Form 4 filed June 4 (sale executed June 2)

Background

SEC Form 4 discloses insider trades by directors/officers/10% owners; these are often routine and can be scheduled or discretionary.

Company-level read

Ticker impact

$KEYSNeutralMedium confidence
Context

Keysight director Cullen James sold 3,000 shares in an open-market transaction disclosed via SEC Form 4 on June 2.

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment/flow effects.

Evidence & confidence

The filing is a routine insider transaction datapoint with no accompanying earnings/guidance, contract, or legal catalyst in the article. The lack of a stated 10b5-1 plan can matter for interpretation, but the sale size (~$1.04M) is not clearly material relative to the company.

Market effects

Minimal; this is company-specific insider activity without a broader instrumentation/tech read-across in the article.

None indicated.

None indicated.

Counterpoint

The sale could be unrelated to outlook (taxes, diversification, liquidity needs), so it may not warrant bearish positioning.

Key entities

  • Keysight Technologies, Inc.

    Subject of the SEC Form 4 insider sale by director Cullen James.

  • Cullen James

    Director who sold 3,000 shares of KEYS on June 2, disclosed June 4.

Related articles

$KEYSMed

Keysight's RFPro Software Certified for Intel's 14A and 18A-P Process Technologies

Keysight Technologies said its RFPro electromagnetic design software has been certified for Intel Foundry’s 14A and 18A-P process technologies, allowing chip designers to simulate performance before manufacturing. The company said this builds on existing support for Intel’s 18A and EMIB-T packaging. The article notes KEYS shares fell about 3.6% to $307.25 and Intel about 3.1% to $89.47.

$KEYSMed

Keysight Technologies, Inc.: Keysight and Sateliot Selected by European Space Agency to Develop Blockchain-Enabled Framework for 5G Non-Terrestrial Networks

Keysight Technologies (NYSE: KEYS) was selected by the European Space Agency to lead a three-year ESA ARTES program developing a blockchain-enabled, secure anomaly detection framework for 5G non-terrestrial networks. Keysight will work with Sateliot on technical development and satellite mission integration, aiming to support trusted NTN operations and future 6G/AI network assurance.

$KEYSMed

Morgan Stanley Says This AI Pick and Shovel Stock Has 25% Upside

Morgan Stanley upgraded Keysight Technologies (NYSE: KEYS) to Overweight from Equal Weight and raised its price target to $400 from $350. The target implies about 25% upside versus a $319 share price. The firm cites Keysight as an AI “pick-and-shovel” for testing at higher networking speeds and notes strong AI-related revenue growth.

$AXPMed

American Express, Biogen upgraded: Wall Street's top analyst calls

Wall Street analysts issued multiple rating changes. JPMorgan raised American Express (AXP) to Overweight, PT $400. Truist upgraded Biogen (BIIB) to Buy, PT $235, citing upcoming Phase 2 and Phase 3 readouts. JPMorgan also raised Keysight (KEYS) to Overweight, PT $400. Other actions included upgrades for Humana (HUM) and downgrades for Papa John’s (PZZA) and Best Buy (BBY).

$KEYSMedAI 8/10

Cybeats Technologies Corp.: Cybeats Technologies Corp. Announces First Quarter Fiscal 2026 Financial Results

Cybeats Technologies Corp. reported Q1 fiscal 2026 results for the three months ended March 31, 2026. Revenue rose to $763,679 from $681,128 (+12%). Net loss widened to $2,430,993 from $1,185,102, with cash expenses down ~15% to $1,620,766. Cash fell to $1,072,900 from $2,751,202. The company also cited a Keysight OEM partnership and an automotive contract, and said it aims to reach ~$5M ARR by end of Q2 2026.

$KEYSLow

Keysight Tackles Semiconductor Talent Gap with Executable RF Design Whiteboard

Keysight Technologies said its RF Circuit Simulation Professional software now includes an “executable whiteboard” that captures an engineer’s RF design workflow—simulations, optimizations, decision trees, and parameters—into editable Python code. Keysight says the code can be saved, shared, and reused across Keysight ADS, Cadence Virtuoso, and Synopsys Custom Compiler. The company cited McKinsey’s estimate of an 88,000-engineer semiconductor gap by 2029.